TEANECK NJ APRIL 25, 2016 NEW TREATMENT FOR KERATOCONUS RECENTLY APPROVED
A new treatment for keratoconus, called corneal collagen crosslinking (CXL), was approved by the U.S. Food and Drug Administration on April 18, 2016. The approval was granted to Avedro, Inc. for Photrexa Viscous, Photrexa and the KXL System. Collagen crosslinking uses a combination of riboflavin (a form of vitamin B2) and ultraviolet light. When use… Read More
What is the Cause of Dry Eye?
The human eye relies a lot on tears to supply lubrication and moisture so that you can maintain your vision and comfort. You might be surprised to learn that tears are a combination of quite a few elements: water, oil, mucus, antibodies and proteins. Once these essential components are gathered, the human eyes special glands… Read More
5 Tips to Help Protect Your Vision in a Digital World
In an increasingly digital world issues such as digital eye strain are becoming more prevalent than ever before. The use of digital devices has become so ingrained in our day-to-day lives that we would have trouble surviving without them both professionally and personally. Every year that goes by we become even more dependent on these… Read More
